Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway

Journal of Immunology

Volumn 162, Issue 4, 1999, Pages 1988-1993

  Furuke, Keizo ^a   Shiraishi, Mitsuhiro ^a   Mostowski, Howard S ^a   Bloom, Eda T ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CD16 ANTIGEN; FAS LIGAND; HYDROGEN PEROXIDE; INTERLEUKIN 2; MONOCLONAL ANTIBODY; NUCLEAR FACTOR; PHOSPHOPROTEIN PHOSPHATASE; REDUCING AGENT; THIOL DERIVATIVE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; CALCINEURIN; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FAS LIGAND PROTEIN; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-2; INTRACELLULAR FLUID; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; OXIDATION-REDUCTION; PEROXIDES; RECEPTORS, IGG; RNA, MESSENGER; SULFHYDRYL COMPOUNDS; T-LYMPHOCYTES; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0033557724     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569.
2. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
3. Dhein, J., H. Walczak, C. Bäumier, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373.438.
4. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynchi, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
5. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
6. Eischen, C. M., J. D. Schilling, D. H. Lynch, P. H. Krammer, and P. J. Leibson. 1996. Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis J. Immunol. 156:2693.
7. Eischen, C. M., B. L. Williams, W. Zhang, L. E. Samelson, D. H. Lynch, R. T. Abraham, and P. J. Leibson. 1997. ZAP-70 tyrosine kinase is required for the up-regulalion of Fas ligand in activation-induced T cell apoptosis. J. Immunol. 159:1135.
8. Latinis, K. M., L. L. Carr, E. J. Peterson, L. A. Norian, S. L. Eliason, and G. A. Koretsky. 1997. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158:4602.
9. Brunner, T., N. J. Yoo, D. LaFace, C. F. Ware, and D. R. Green. 1996. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. Int. Immunol. 8:1017.
10. Yang, Y., S. Minucci, K. Ozato, R. A. Heyman, and J. D. Ashwell. 1995. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J. Biol. Chem. 270:18672.
11. Latinis, K. M., L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272:31427.
12. Matsui, K., S. Omura, H. Cui, S. L. Schauer, G. E. Sonenshein, and S.-T. Ju. 1997. Proteasome regulation of Fas ligand cytotoxicity. Eur. J. Immunol. 27: 2269.
13. Monteiro, H. P., and A. Stern. 1996. Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. Free Radical Biol. Med. 21:323.
14. Sun, Y., and L. W. Oberley. 1996. Redox regulation of transcriptional activators Free Radical Biol. Med. 21:335.
15. Yamauchi, A., and E. T. Bloom. 1993. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells. J. Immunol. 151:5535.
16. Yamauchi, A., and E. T. Bloom. 1997 Control of cell cycle progression human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein. Blood 89:4092.
17. Furuke, K., and E. T. Bloom. 1998. Redox-sensitive events in Fas-induced apoptosis in human natural killer cells include ceramide generation and protein tyrosine dephosphorylation. Int. Immunol. 10:1261.
18. Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1777.
19. Furuke, K., T. Sasada, Y. Ueda-Taniguchi, A. Yamauchi, T. Inamoto, Y. Yamaoka, H. Masutani, and J. Yodoi. 1997. Role of intracellular redox status in apoptosis induction of human T-cell leukemia virus type I-infected lymphocytes by 13-cis-retinoic acid. Cancer Res. 57:4916.
20. Burd, P. R., W. C. Thompson, E. E. Max, and F. C. Mills. 1995. Activated mast cells secrete interleukin-13. J. Exp. Med. 181:1373.
21. Schreiber, E., P. Matthias, M. M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419.
22. Jain, J., Z. Miner, and A. Rao. 1993. Analysis of the pre-existing and nuclear forms of nuclear factor of activated T cells. J. Immunol. 151:837.
23. Aramburu, J., L. Azzoni, A. Rao, and B. Perussia. 1995. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. J. Exp. Med. 182:801.
24. Fruman, D. A., C. B. Klee, B. E. Bierer, and S. J. Burakoff. 1992. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA 89:3686.
25. Burow, S., and G. Valet. 1987. Flow-cytometric characterization of stimulation, free radical formation, peroxidase activity and phagocytosis of human granulocytes with 2,7-dichlorofluorescein (DCF). Eur. J. Cell Biol. 43:128.
26. Lahdenpohja, N., K. Savinainen, and M. Hurme. 1998. Pre-exposure to oxidative stress decreases the nuclear factor-K B-dependent transcription in T lymphocytes. J. Immunol. 160:1354.
27. Holtz-Heppelmann, C. J., A. Algeciras, A. D. Badley, and C. V. Paya. 1998. Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 273:4416.
28. Schreiber, S. L., and G. R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13:136.
29. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247.
30. Abate, C., L. Patel, F. J. Rauscher III, and T. Curran. 1990. Redox regulation of Fos and Jun DNA binding activity in vitro. Science 249:1157.
31. Galter, D. S., S. Mihm, and W. Dröge. 1994. Distinct effects of glutathione disulphide on the nuclear transcription factors κB and the activator protein-1. Eur. J. Biochem. 221:639.
32. Hayashi, T., Y. Ueno, and T. Okamoto. 1993. Oxidoreductive regulation of nuclear factor κB. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268:11380.
33. Beiqing, L., M. Chen, and R. L. Whisler. 1996. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells. J. Immunol. 157:160.
34. Wang, X., V. C. Culotta, and C. B. Klee. 1996. Superoxide dismutase protects calcineurin from inactivation. Nature 383:434.
35. Furuke, K., H. Nakamura, T. Hori, S. Iwata, N. Maekawa, T. Inamoto, Y. Yamaoka, and J. Yodoi. 1995. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control. Int. Immunol. 7:985.
36. Kissinger, C. R., H. E. Parge, D. R. Knighton, C. T. Lewis, L. A. Pelletier, A. Tempczyk, V. J. Kalish, K. D. Tucker, R. E. Showalter, E. W. Moomaw, et al. 1995. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 378:641.
37. Walker, P. R., P. Saas, and P.-Y. Dietrich. 1997. Role of Fas ligand (CD95L) in immure escape the tumor cell strikes back. J. Immunol. 158:4521.
38. De Maria, R., and R. Testi. 1998. Fas-FasL interactions: a common pathogenelic mechanism in organ-specific autoimmunity. Immunol. Today 19:121.
39. Sakata, K.-m., A. Sakata, L. Kong, H. Dang, and N. Talal. 1998. Role of Fas/FasL interaction in physiology and pathology: the good and the bad. Clin. Immunol. Immunopathol. 87:1.
40. Halliwell, B., and J. M. C. Gutteridge. 1990. Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol. 186:1.
41. Delneste, Y., P. Jeannin, E. Sebille, J.-P. Aubry, and J.-Y. Bonnefoy. 1996. Thiols prevent Fas (CD95)-mediated T cell apoptosis by down-regulating membrane Fas expression. Eur. J. Immunol. 26:2981.
42. Suhara, T., K. Fukuo, T. Sugimoto, S. Morimoto, T. Nakahashi, S. Hata, M. Shimizu, and T. Ogihara. 1998. Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. J. Immunol. 160:4042.
43. Williams, M. S., and P. A. Henkart. 1996. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol. 157:2395.
44. Bauer, M. K. A., M. Vogt, M. Los, J. Siegel, S. Wasselborg, and K. Schulze-Osthoff. 1998. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J. Biol. Chem. 273:8045.